Brookside Energy’s record-breaking cash flow, soaring production, and strategic U.S. expansion solidify its position as a dual-listed energy powerhouse.
Argenica Therapeutics (ASX:AGN) moves closer to a potential breakthrough in stroke treatment as its Phase 2 trial of ARG-007 nears completion with a final safety endorsement from the DSMB.
Warriedar’s initial aircore drilling at Golden Range has identified high-grade gold and uncovered promising new targets for future exploration.
Medallion Metals is forging ahead with its Ravensthorpe Gold Project, uncovering promising continuity in mineralisation at the Harbour View deposit and setting the stage for a transformative production hub in Western Australia.
EV Resources acquisition of the Los Lirios Antimony Mine highlights exceptional high-grade potential, with assays of up to 62.99% antimony.
Altech Batteries CERENERGY® project, rated “Dark Green” by S&P Global Ratings, sets a new benchmark in sustainable energy storage with ultra-low emissions, renewable-powered production, and recyclable materials.
The Guyer Trend, part of Iceni Gold’s 14 Mile Well Project, is located between the historic gold hubs of Leonora and Laverton in Western Australia’s Eastern Goldfields.
Island Pharmaceuticals groundbreaking PROTECT trial advances with full enrolment in Phase 2b, aiming to combat dengue fever through the repurposed antiviral ISLA-101.
Bleiberg’s Ge76 confirmation positions the historic Austrian mine as a potential linchpin in securing Europe’s critical mineral supply for the booming semiconductor industry.
Brazilian Critical Minerals Ema project is poised to challenge the global rare earths market with its low-impact, high-grade potential, offering a sustainable alternative to traditional mining.